Sautter-Bihl M L, Bihl H, Heinze H G
Klinik für Strahlentherapie und Nuklearmedizin, Städt. Klinikum, Karlsruhe.
Nuklearmedizin. 1991 Feb;30(1):7-12.
The present study compares the reliability of MIBG and MDP bone scans in detecting bone metastases of neuroblastoma. Out of 57 patients, 23 had both 99mTc-MDP and 123I/131I-MIBG scans within a 2-week period. In 10 patients at primary diagnosis there was an underestimation of skeletal involvement by MIBG in 1/5, in 13 patients at follow-up in 3/9; 99mTc-MDP scans were able to visualize skeletal involvement in all those cases. There was only one false positive MDP scan. These results suggest that MIBG alone may fail to visualize skeletal involvement of neuroblastoma and should therefore be complemented by additional 99mTc-MDP scintigraphy.
本研究比较了间碘苄胍(MIBG)和亚甲基二膦酸盐(MDP)骨扫描在检测神经母细胞瘤骨转移方面的可靠性。57例患者中,23例在2周内同时进行了99m锝-亚甲基二膦酸盐(99mTc-MDP)和123碘/131碘-间碘苄胍(123I/131I-MIBG)扫描。在10例初诊患者中,MIBG低估骨骼受累情况的比例为1/5;在13例随访患者中,该比例为3/9;而99mTc-MDP扫描能够在所有这些病例中显示骨骼受累情况。MDP扫描仅出现1例假阳性结果。这些结果表明,单独使用MIBG可能无法显示神经母细胞瘤的骨骼受累情况,因此应辅以额外的99mTc-MDP闪烁显像。